EMA Authorised: Epidyolex (cannabidiol) — Jazz Pharmaceuticals Ireland Limited

View source ↗

Summary

Epidyolex (cannabidiol) has been authorised by the EMA for Lennox-Gastaut syndrome and myoclonic epilepsies, with Jazz Pharmaceuticals Ireland Limited as the MA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome
• Myoclonic Epilepsies

Drugs mentioned

• Epidyolex (cannabidiol)

Snippet

Status: Authorised. Therapeutic area: Lennox Gastaut Syndrome;Epilepsies, Myoclonic. MAH: Jazz Pharmaceuticals Ireland Limited. Decision date: 12/03/2026. Orphan medicine